Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca

Date: 29/01/2021
Location: Virtual meeting

Event summary

This virtual press briefing will discuss the outcome of the evaluation of COVID-19 Vaccine AstraZeneca by EMA’s human medicines committee (CHMP).

Speakers include:

  • Emer Cooke (EMA's Executive Director)
  • Bruno Sepodes (CHMP Vice-chair)
  • Sabine Straus (PRAC Chair)
  • Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy).

Marie-Agnes Heine, EMA's Head of Communication, will moderate the press briefing.

The press briefing is held in English. 

Video recording

How useful was this page?

Add your rating
6 ratings
1 rating
1 rating
1 rating